ARTICLE | Company News
Oxford BioMedica, sanofi-aventis deal
May 4, 2009 7:00 AM UTC
sanofi-aventis returned to Oxford BioMedica rights to TroVax following a review of the pharma's R&D portfolio. Oxford BioMedica will receive a $16.5 million payment, including a settlement of previou...